FDA Approves Kedrion’s Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®
Press Releases
Kedrion Biopharma  
November 21, 2024

FDA Approves Kedrion’s Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim®

FORT LEE, N.J., Nov. 19, 2024 /PRNewswire/ -- Kedrion Biopharma Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the company's manufacturing facility in

avatar profile Olean Times Herald

Olean Times Herald


Local & Social